Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2025-12-24 @ 3:15 PM
NCT ID:
NCT00162292
Eligibility Criteria:
Inclusion Criteria:
* Age 18-70 years
* Diagnosis of RA for ≥6 months
* Swollen or tender joint or ESR \>ULN. Subject must be on stable doses of MTX
* Women of Childbearing Potential
Exclusion Criteria:
* Serum transaminase levels \>ULN
* CK\>ULN
* Cannot have taken Orencia or Remicade within 8 weeks of baseline, Humira or Enbrel within 4 weeks of baseline
* Use of H2 blockers or Proton Pump inhibitors while on study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00162292
Study Brief:
Protocol Section:
NCT00162292